Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B
17 May 2013 | By Novo Nordisk
Novo Nordisk announced the completion of paradigm™ 2...
List view / Grid view
News
Novartis wins GBCHealth Business Action on Health Award for social ventures initiative
17 May 2013 | By Novartis
"We are proud to be recognized by GBCHealth for our Arogya Parivar program..."
Sanofi announces the next steps of its Research site in Toulouse, France
17 May 2013 | By Sanofi
The French ministerial mission has presented the conclusions of its report regarding the Sanofi Research site in Toulouse, France...
Could a ‘super computer’ help improve epilepsy care? Yes, it’s elementary my dear WATSON
16 May 2013 | By UCB
UCB and IBM have announced the completion of the initial phase of a pioneering project...
Promising new data demonstrate that a novel pain therapy system manages patients with chronic neuropathic pain
16 May 2013 | By Biosector 2
Spinal Modulation Inc. designed the Axium™ Spinal Cord Stimulator System...
Roche’s obinutuzumab significantly reduced the risk of disease progression or death in people with one of the most common forms of blood cancer
16 May 2013 | By Roche
First results from CLL11 announced...
AstraZeneca issues update on accelerated oncology pipeline in advance of 2013 ASCO Annual Meeting
16 May 2013 | By AstraZeneca
First patient enrolled in Phase III clinical trial...
Biogen Idec Foundation awards $250,000 to East End House to develop genetics education program
16 May 2013 | By Biogen Idec
“Biogen Idec Foundation & East End House share an ongoing commitment..."
Gilead announces response data from Phase 2 study of idelalisib for previously untreated CLL
15 May 2013 | By Gilead Sciences
Gilead Sciences, Inc. announced results from a Phase 2 study...
Astellas to restructure, close some research units
15 May 2013 | By Astellas
Astellas Pharma announces plans to reshape its research framework to further enhance the ability to generate innovative drugs...
FDA approves Tarceva (Erlotinib) tablets for specific type of lung cancer
15 May 2013 | By Astellas Pharma Inc.
The FDA also approved the cobas® EGFR Mutation Test, which was developed by Roche and validated in the pivotal EURTAC study...
Roche to present important new data reflecting broad cancer pipeline at ASCO
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
Sanofi and Regeneron announce patient enrollment in two Phase 3 trials with sarilumab in RA
15 May 2013 | By Sanofi
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials...
Lonza launches 2013-2014 BioResearch Catalog
Diabetes prevention has become a key focus area for the drug development market.
Ranbaxy announces conclusion of previously disclosed investigation by U.S Department of Justice
13 May 2013 | By DAIICHI SANKYO COMPANY, LIMITED
"Today’s announcement marks the resolution of this past issue..."
